Abstract
Esophageal atresia (EA) is a rare congenital defect where the esophagus, during the early stages of development, does not fully form. This causes there to be no connection between the oral cavity and the stomach. Complications with EA treatment come into play when there is a long gap between the two segments of the esophagus, meaning they cannot simply be sewed together using anastomosis. A new device called Flourish has recently been approved by the FDA and may be a new and more humanitarian approach to solving long gap esophageal atresia in infants.
Recommended Citation
Llorente, Gabriella
(2024)
"Revolutionizing Esophageal Atresia Treatment: Newly Approved Technique to Bypass Surgery,"
Mako: NSU Undergraduate Student Journal: Vol. 2024, Article 2.
Available at:
https://nsuworks.nova.edu/mako/vol2024/iss1/2